Giess C S, Keating D M, Osborne M P, Rosenblatt R
Department of Radiology, New York Presbyterian Hospital-Weill Medical College of Cornell University, Strang Cornell Breast Center, USA.
Radiology. 1999 Sep;212(3):829-35. doi: 10.1148/radiology.212.3.r99se41829.
To correlate histopathologic findings with detection method and mammographic appearance in primary and locally recurrent breast carcinoma after breast-conservation therapy.
Medical records and mammographic findings were retrospectively reviewed; 26 patients with 27 local recurrences after breast-conservation therapy were identified.
Primary histopathologic findings included six in situ and 20 invasive carcinomas. Of the 27 recurrences, 19 (70%) were at or adjacent to the lumpectomy site and eight (30%) were elsewhere in the breast. All primary ductal carcinoma in situ (DCIS) cases manifested mammographically as microcalcifications and recurred as DCIS with microcalcifications. Eleven primary invasive carcinomas (10 masses, one case of microcalcifications) were detected only mammographically, three were detected only with physical examination, and six (six masses) were detected with both. Among these 20 recurrences, 14 (five masses, nine cases of microcalcifications) were detected only mammographically, one was detected only with physical examination, and five (five masses) were detected with both. Seventeen (85%) of 20 primary invasive carcinomas recurred invasively: 16 (94%) with similar histopathologic findings and eight (47%) with similar mammographic findings.
In local recurrence after breast-conservation therapy for DCIS, histopathologic findings, detection method, and mammographic findings are usually similar. Histopathologic findings of primary invasive breast carcinoma and local recurrence are usually similar, but the detection method and mammographic findings vary. This is relevant to the interpretation of new clinical or mammographic findings following lumpectomy.
将保乳治疗后原发性及局部复发性乳腺癌的组织病理学结果与检测方法及乳腺钼靶表现进行关联分析。
回顾性分析病历及乳腺钼靶检查结果;共纳入26例保乳治疗后出现27处局部复发的患者。
原发性组织病理学结果包括6例原位癌和20例浸润性癌。在27处复发中,19处(70%)位于或邻近肿块切除部位,8处(30%)位于乳腺其他部位。所有原发性导管原位癌(DCIS)病例在乳腺钼靶上均表现为微钙化,并以伴有微钙化的DCIS形式复发。11例原发性浸润性癌(10例为肿块,1例为微钙化)仅通过乳腺钼靶检测到,3例仅通过体格检查发现,6例(6个肿块)通过两者均能检测到。在这20处复发中,14处(5个肿块,9例微钙化)仅通过乳腺钼靶检测到,1处仅通过体格检查发现,5处(5个肿块)通过两者均能检测到。20例原发性浸润性癌中有17例(85%)复发为浸润性癌:16例(94%)组织病理学结果相似,8例(47%)乳腺钼靶表现相似。
在DCIS保乳治疗后的局部复发中,组织病理学结果、检测方法及乳腺钼靶表现通常相似。原发性浸润性乳腺癌与局部复发的组织病理学结果通常相似,但检测方法及乳腺钼靶表现有所不同。这对于肿块切除术后新的临床或乳腺钼靶检查结果的解读具有重要意义。